Operating Lease, Right-of-Use Asset in USD of Verona Pharma plc from Q4 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Verona Pharma plc quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2019 to Q2 2025.
  • Verona Pharma plc Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $1,574,000.000, a 29.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Verona Pharma plc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $1,574,000 -$668,000 -29.8% 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $1,810,000 -$695,000 -27.7% 31 Mar 2025 10-Q 29 Apr 2025
Q4 2024 $2,048,000 -$799,000 -28.1% 31 Dec 2024 10-Q 06 Aug 2025
Q3 2024 $1,980,000 +$1,592,000 +4.1% 30 Sep 2024 10-Q 04 Nov 2024
Q2 2024 $2,242,000 +$1,700,000 +3.1% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $2,505,000 +$1,807,000 +2.6% 31 Mar 2024 10-Q 10 May 2024
Q4 2023 $2,847,000 +$1,993,000 +2.3% 31 Dec 2023 10-K 27 Feb 2025
Q3 2023 $388,000 -$405,000 -51.1% 30 Sep 2023 10-Q 02 Nov 2023
Q2 2023 $542,000 -$46,000 -7.8% 30 Jun 2023 10-Q 03 Aug 2023
Q1 2023 $698,000 -$46,000 -6.2% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $854,000 -$45,000 -5% 31 Dec 2022 10-K 29 Feb 2024
Q3 2022 $793,000 -$642,000 -44.7% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $588,000 -$997,000 -62.9% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $744,000 -$162,000 -17.9% 31 Mar 2022 10-Q 03 May 2022
Q4 2021 $899,000 -$151,000 -14.4% 31 Dec 2021 10-K 07 Mar 2023
Q3 2021 $1,435,000 30 Sep 2021 10-Q 09 Nov 2021
Q2 2021 $1,585,000 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $906,000 31 Mar 2021 10-Q 29 Apr 2021
Q4 2020 $1,050,000 -$238,000 -18.5% 31 Dec 2020 10-K 03 Mar 2022
Q4 2019 $1,288,000 31 Dec 2019 10-K 25 Feb 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.